PB2133: TRIAL IN PROGRESS: LINKER-MM3, A PHASE 3, OPEN-LABEL, RANDOMIZED STUDY OF LINVOSELTAMAB VERSUS ELOTUZUMAB, POMALIDOMIDE, AND DEXAMETHASONE (EPD) IN RELAPSED/REFRACTORY MULT...

por Weisel, Katja, Hungria, Vania, Quach, Hang, Yoon, Sung-Soo, Rodríguez-Otero, Paula, Kroog, Glenn, Sinha, Arijit, Boyapati, Anita, Lyon, Charlotte, Lorenc, Karen Rodriguez, Inocencio, Timothy, Harnett, James, Chi, Lei, Moore, Vygngley, Voorhees, Peter
Publicado 2023